Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators

Click to copy article linkArticle link copied!

This article is cited by 152 publications.

1. Julia J. Lee, Ziwei Hu, Yuhong Anna Wang, Dinesh Nath, Wentao Liang, Yi Cui, Jian-Xing Ma, Adam S. Duerfeldt. Design, Synthesis, and Structure–Activity Relationships of Biaryl Anilines as Subtype-Selective PPAR-alpha Agonists. ACS Medicinal Chemistry Letters 2023, 14 (6) , 766-776. https://doi.org/10.1021/acsmedchemlett.3c00056
2. Zhiqi Feng, Jiehao Xiang, Gang Sun, Hui Liu, Yanyan Wang, Xin Liu, Jin Feng, Qinglong Xu, Xiaoan Wen, Haoliang Yuan, Hongbin Sun, Liang Dai. Discovery of the First Subnanomolar PPARα/δ Dual Agonist for the Treatment of Cholestatic Liver Diseases. Journal of Medicinal Chemistry 2023, 66 (11) , 7331-7354. https://doi.org/10.1021/acs.jmedchem.2c02123
3. Gavin O’Mahony, Jens Petersen, Margareta Ek, Rebecca Rae, Carina Johansson, Liu Jianming, Nina Prokoph, Fredrik Bergström, Krister Bamberg, Fabrizio Giordanetto, Bader Zarrouki, Daniel Karlsson, Anders Hogner. Discovery by Virtual Screening of an Inhibitor of CDK5-Mediated PPARγ Phosphorylation. ACS Medicinal Chemistry Letters 2022, 13 (4) , 681-686. https://doi.org/10.1021/acsmedchemlett.1c00715
4. Zhiqi Feng, Jiehao Xiang, Hui Liu, Jiaxin Li, Xiangrui Xu, Gang Sun, Runan Zheng, Shangran Zhang, Junlong Liu, Shanlin Yang, Qinglong Xu, Xiaoan Wen, Haoliang Yuan, Hongbin Sun, Liang Dai. Design, Synthesis, and Biological Evaluation of Triazolone Derivatives as Potent PPARα/δ Dual Agonists for the Treatment of Nonalcoholic Steatohepatitis. Journal of Medicinal Chemistry 2022, 65 (3) , 2571-2592. https://doi.org/10.1021/acs.jmedchem.1c02002
5. Zhipeng Zhang, Yanqiu Meng, Zhan Wang, Yu Mei, Shite Gao, Yuejiao Wu, Shuxian Du. Discovery of Potent Glucokinase and PPARγ Dual-Target Agonists through an Innovative Scheme for Regioselective Modification of Silybin. ACS Omega 2022, 7 (4) , 3812-3822. https://doi.org/10.1021/acsomega.1c06778
6. Yong-Jin Wu, Nicholas A. Meanwell. Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design. Journal of Medicinal Chemistry 2021, 64 (14) , 9786-9874. https://doi.org/10.1021/acs.jmedchem.1c00790
7. Konstantin Hinnah, Sabine Willems, Johannes Morstein, Jan Heering, Felix W. W. Hartrampf, Johannes Broichhagen, Philipp Leippe, Daniel Merk, Dirk Trauner. Photohormones Enable Optical Control of the Peroxisome Proliferator-Activated Receptor γ (PPARγ). Journal of Medicinal Chemistry 2020, 63 (19) , 10908-10920. https://doi.org/10.1021/acs.jmedchem.0c00654
8. Xiaozheng Dou, Dinesh Nath, Henry Shin, Elmar Nurmemmedov, Philip C. Bourne, Jian-Xing Ma, Adam S. Duerfeldt. Evolution of a 4-Benzyloxy-benzylamino Chemotype to Provide Efficacious, Potent, and Isoform Selective PPARα Agonists as Leads for Retinal Disorders. Journal of Medicinal Chemistry 2020, 63 (6) , 2854-2876. https://doi.org/10.1021/acs.jmedchem.9b01189
9. Leonardo Brunetti, Fulvio Loiodice, Luca Piemontese, Paolo Tortorella, Antonio Laghezza. New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation. Journal of Medicinal Chemistry 2019, 62 (24) , 10995-11003. https://doi.org/10.1021/acs.jmedchem.9b00885
10. Almudena Bermejo, Aida Collado, Isabel Barrachina, Patrice Marqués, Noureddine El Aouad, Xavier Franck, Francisco Garibotto, Catherine Dacquet, Daniel H. Caignard, Fernando D. Suvire, Ricardo D. Enriz, Laura Piqueras, Bruno Figadère, María-Jesús Sanz, Nuria Cabedo, Diego Cortes. Polycerasoidol, a Natural Prenylated Benzopyran with a Dual PPARα/PPARγ Agonist Activity and Anti-inflammatory Effect. Journal of Natural Products 2019, 82 (7) , 1802-1812. https://doi.org/10.1021/acs.jnatprod.9b00003
11. Yan Shi, Jun Li, Lawrence J. Kennedy, Shiwei Tao, Andrés S. Hernández, Zhi Lai, Sean Chen, Henry Wong, Juliang Zhu, Ashok Trehan, Ngiap-Kie Lim, Huiping Zhang, Bang-Chi Chen, Kenneth T. Locke, Kevin M. O’Malley, Litao Zhang, Rai Ajit Srivastava, Bowman Miao, Daniel S. Meyers, Hossain Monshizadegan, Debra Search, Denise Grimm, Rongan Zhang, Thomas Harrity, Lori K. Kunselman, Michael Cap, Jodi Muckelbauer, Chiehying Chang, Stanley R. Krystek, Yi-Xin Li, Vinayak Hosagrahara, Lisa Zhang, Pathanjali Kadiyala, Carrie Xu, Michael A. Blanar, Robert Zahler, Ranjan Mukherjee, Peter T. W. Cheng, and Joseph A. Tino . Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARα Selective Agonist. ACS Medicinal Chemistry Letters 2016, 7 (6) , 590-594. https://doi.org/10.1021/acsmedchemlett.6b00033
12. Shuai Zhao, Yuichiro Kanno, Wei Li, Honami Wakatabi, Tatsunori Sasaki, Kazuo Koike, Kiyomitsu Nemoto, and Huicheng Li . Picrasidine N Is a Subtype-Selective PPARβ/δ Agonist. Journal of Natural Products 2016, 79 (4) , 879-885. https://doi.org/10.1021/acs.jnatprod.5b00909
13. Alice Asteian, Anne-Laure Blayo, Yuanjun He, Marcel Koenig, Youseung Shin, Dana S. Kuruvilla, Cesar A. Corzo, Michael D. Cameron, Li Lin, Claudia Ruiz, Susan Khan, Naresh Kumar, Scott Busby, David P. Marciano, Ruben D. Garcia-Ordonez, Patrick R. Griffin, and Theodore M. Kamenecka . Design, Synthesis, and Biological Evaluation of Indole Biphenylcarboxylic Acids as PPARγ Antagonists. ACS Medicinal Chemistry Letters 2015, 6 (9) , 998-1003. https://doi.org/10.1021/acsmedchemlett.5b00218
14. N. Fresno, M. Macías-González, A. Torres-Zaguirre, M. Romero-Cuevas, P. Sanz-Camacho, J. Elguero, F. J. Pavón, F. Rodríguez de Fonseca, P. Goya, and R. Pérez-Fernández . Novel Oxazolidinone-Based Peroxisome Proliferator Activated Receptor Agonists: Molecular Modeling, Synthesis, and Biological Evaluation. Journal of Medicinal Chemistry 2015, 58 (16) , 6639-6652. https://doi.org/10.1021/acs.jmedchem.5b00849
15. Santiago Garcia-Vallvé, Laura Guasch, Sarah Tomas-Hernández, Josep Maria del Bas, Vincent Ollendorff, Lluís Arola, Gerard Pujadas, and Miquel Mulero . Peroxisome Proliferator-Activated Receptor γ (PPARγ) and Ligand Choreography: Newcomers Take the Stage. Journal of Medicinal Chemistry 2015, 58 (14) , 5381-5394. https://doi.org/10.1021/jm501155f
16. Sirish Kaushik Lakkaraju, Wenbo Yu, E. Prabhu Raman, Alena V. Hershfeld, Lei Fang, Deepak A. Deshpande, and Alexander D. MacKerell, Jr. . Mapping Functional Group Free Energy Patterns at Protein Occluded Sites: Nuclear Receptors and G-Protein Coupled Receptors. Journal of Chemical Information and Modeling 2015, 55 (3) , 700-708. https://doi.org/10.1021/ci500729k
17. Estel.la Buscató, René Blöcher, Christina Lamers, Franca-Maria Klingler, Steffen Hahn, Dieter Steinhilber, Manfred Schubert-Zsilavecz, and Ewgenij Proschak . Design and Synthesis of Dual Modulators of Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptors. Journal of Medicinal Chemistry 2012, 55 (23) , 10771-10775. https://doi.org/10.1021/jm301194c
18. Carmen Festa, Gianluigi Lauro, Simona De Marino, Maria Valeria D’Auria, Maria Chiara Monti, Agostino Casapullo, Claudio D’Amore, Barbara Renga, Andrea Mencarelli, Sylvain Petek, Giuseppe Bifulco, Stefano Fiorucci, and Angela Zampella . Plakilactones from the Marine Sponge Plakinastrella mamillaris. Discovery of a New Class of Marine Ligands of Peroxisome Proliferator-Activated Receptor γ. Journal of Medicinal Chemistry 2012, 55 (19) , 8303-8317. https://doi.org/10.1021/jm300911g
19. Qixin Wu, Yue Jiao, Jingzhe Li, Yanyan Ma, Jingyi Wang, Mingzhu Luo, Yiting Wang, Xinrong Fan, Changzhen Liu. Flavokawain B is an effective natural peroxisome proliferator-activated receptor γ-selective agonist with a strong glucose-lowering effect. Biochemical Pharmacology 2024, 37 , 116548. https://doi.org/10.1016/j.bcp.2024.116548
20. Raymond L. Konger, Xiaoling Xuei, Ethel Derr-Yellin, Fang Fang, Hongyu Gao, Yunlong Liu. The Loss of PPARγ Expression and Signaling Is a Key Feature of Cutaneous Actinic Disease and Squamous Cell Carcinoma: Association with Tumor Stromal Inflammation. Cells 2024, 13 (16) , 1356. https://doi.org/10.3390/cells13161356
21. Jing Yu, Yongjun Du, Chang Liu, Yu Xie, Mengci Yuan, Meihua Shan, Ning Li, Chang Liu, Yue Wang, Junfang Qin. Low GPR81 in ER+ breast cancer cells drives tamoxifen resistance through inducing PPARα-mediated fatty acid oxidation. Life Sciences 2024, 21 , 122763. https://doi.org/10.1016/j.lfs.2024.122763
22. Gang Sun, Zhiqi Feng, Yufan Kuang, Zhuoxin Fu, Yanyan Wang, Xing Zhao, Fengqin Wang, Hongbin Sun, Haoliang Yuan, Liang Dai. Design, synthesis, and biological evaluation of piperazine derivatives as pan-PPARs agonists for the treatment of liver fibrosis. European Journal of Medicinal Chemistry 2024, 269 , 116344. https://doi.org/10.1016/j.ejmech.2024.116344
23. Qingqing Ke, Yu Xiao, Dandan Liu, Caifeng Shi, Rui Shen, Songyan Qin, Lei Jiang, Junwei Yang, Yang Zhou. PPARα/δ dual agonist H11 alleviates diabetic kidney injury by improving the metabolic disorders of tubular epithelial cells. Biochemical Pharmacology 2024, 222 , 116076. https://doi.org/10.1016/j.bcp.2024.116076
24. Supriya Sharma, Divya Sharma, Mahaveer Dhobi, Dongdong Wang, Devesh Tewari. An insight to treat cardiovascular diseases through phytochemicals targeting PPAR-α. Molecular and Cellular Biochemistry 2024, 479 (3) , 707-732. https://doi.org/10.1007/s11010-023-04755-7
25. Mahesha Gangadhariah, Triveni Pardhi, Jahnavi Ravilla, Subhash Chandra, Sridevi Annapurna Singh. Citrus nutraceutical eriocitrin and its metabolites are partial agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a molecular docking and molecular dynamics study. Journal of Biomolecular Structure and Dynamics 2023, 41 (21) , 11373-11393. https://doi.org/10.1080/07391102.2022.2162127
26. Roberta Zupo, Fabio Castellana, Pasquale Crupi, Addolorata Desantis, Mariangela Rondanelli, Filomena Corbo, Maria Lisa Clodoveo. Olive Oil Polyphenols Improve HDL Cholesterol and Promote Maintenance of Lipid Metabolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Metabolites 2023, 13 (12) , 1187. https://doi.org/10.3390/metabo13121187
27. Farooq Riaz, Ping Wei, Fan Pan. PPARs at the crossroads of T cell differentiation and type 1 diabetes. Frontiers in Immunology 2023, 14 https://doi.org/10.3389/fimmu.2023.1292238
28. Si‐Wei Tian, Fang‐Ting Xiong, Bi‐Quan Xiong, Long‐Jin Zhong, Ke‐Wen Tang, Yu Liu. K 2 S 2 O 8 ‐Mediated Radical Cascade Alkylation/Cyclization of Ynones: Access to Oxoalkyl‐Substituted Indenones. ChemistrySelect 2023, 8 (31) https://doi.org/10.1002/slct.202302484
29. Yang Yu, Junyu Wang, Zhiqin He, Yiming Sun, Jonathan B. Baell, Zhifeng Mao, Fei Huang. Carbene insertion reactions for the construction of C   C and C − heteroatom bonds using surface modified Silica microspheres as catalysts. Journal of Catalysis 2023, 424 , 39-49. https://doi.org/10.1016/j.jcat.2023.04.023
30. Jing Wang, Shuangping Chen, Xiuxiu Zhao, Qian Guo, Ruibo Yang, Chen Zhang, Yue Huang, Lechong Ma, Shaozhen Zhao. Effect of PPARγ on oxidative stress in diabetes-related dry eye. Experimental Eye Research 2023, 231 , 109498. https://doi.org/10.1016/j.exer.2023.109498
31. Xiao-Ting Xu, Li-Ying Shi, Yu-Juan Ban, Bi-Lan Luo, Gao-Feng Zhu, Bing Guo, Lei Tang, Zhi-Pei Sang, Jian-Ta Wang. Design, synthesis and biological evaluation of cajanonic acid A analogues as potent PPAR γ antagonists. Bioorganic & Medicinal Chemistry Letters 2023, 80 , 129081. https://doi.org/10.1016/j.bmcl.2022.129081
32. Jean Claude Ansquer. The PPAR System in Diabetes. 2023, 145-167. https://doi.org/10.1007/978-3-031-26681-2_6
33. Elham Razmpoosh, Shima Abdollahi, Mahdieh Mousavirad, Cain C. T. Clark, Sepideh Soltani. The effects of olive leaf extract on cardiovascular risk factors in the general adult population: a systematic review and meta-analysis of randomized controlled trials. Diabetology & Metabolic Syndrome 2022, 14 (1) https://doi.org/10.1186/s13098-022-00920-y
34. Lei Ma, Junyuan Tang, Guihui Cai, Fangyuan Chen, Qingmei Liu, Zhi Zhou, Silin Zhang, Xiawen Liu, Ning Hou, Wei Yi. Structure-based screening and biological validation of the anti-thrombotic drug-dicoumarol as a novel and potent PPARγ-modulating ligand. Bioorganic Chemistry 2022, 129 , 106191. https://doi.org/10.1016/j.bioorg.2022.106191
35. Hai-Xiang Liu, Qing-Jie Liu. Logistic role of carnitine shuttle system on radiation-induced L-carnitine and acylcarnitines alteration. International Journal of Radiation Biology 2022, 98 (11) , 1595-1608. https://doi.org/10.1080/09553002.2022.2063430
36. Mauro Picardo, Carla Cardinali, Michelangelo La Placa, Anita Lewartowska-Białek, Viviana Lora, Giuseppe Micali, Roberta Montisci, Luca Morbelli, Andrea Nova, Aurora Parodi, Adam Reich, Michael Sebastian, Katarzyna Turek-Urasińska, Oliver Weirich, Jacek Zdybski, Christos C. Zouboulis, . Efficacy and safety of N-acetyl-GED-0507-34-LEVO gel in patients with moderate-to severe facial acne vulgaris: a phase IIb randomized double-blind, vehicle-controlled trial. British Journal of Dermatology 2022, 187 (4) , 507-514. https://doi.org/10.1111/bjd.21663
37. Fangyuan Chen, Lei Ma, Guihui Cai, Junyuan Tang, Yi Wang, Qingmei Liu, Xiawen Liu, Ning Hou, Zhi Zhou, Wei Yi. Identification of a novel PPARγ modulator with good anti-diabetic therapeutic index via structure-based screening, optimization and biological validation. Biomedicine & Pharmacotherapy 2022, 154 , 113653. https://doi.org/10.1016/j.biopha.2022.113653
38. Agata Michalak, Beata Kasztelan-Szczerbińska, Halina Cichoż-Lach. Impact of Obesity on the Course of Management of Inflammatory Bowel Disease—A Review. Nutrients 2022, 14 (19) , 3983. https://doi.org/10.3390/nu14193983
39. Qiang Yin, Annoor Awadasseid, Yongnan Zhou, Ming Wang, Xuqiong Xiong, Yanling Wu, Wen Zhang. 4,5-diazafenylfluorene-rhodanine conjugates promote anoikis in A375 cells via inhibiting PPAR-γ expression. Medicinal Chemistry Research 2022, 31 (9) , 1476-1487. https://doi.org/10.1007/s00044-022-02928-5
40. Xiaoping Li, Liufeng Zheng, Bing Zhang, Ze-Yuan Deng, Ting Luo. The Structure Basis of Phytochemicals as Metabolic Signals for Combating Obesity. Frontiers in Nutrition 2022, 9 https://doi.org/10.3389/fnut.2022.913883
41. Muhammad Ajmal Shah, Muhammad Haris, Hafiza Ishmal Faheem, Ayesha Hamid, Rimsha Yousaf, Azhar Rasul, Ghulam Mujtaba Shah, Atif Ali Khan Khalil, Abdul Wahab, Haroon Khan, Reem Hasaballah Alhasani, Norah A. Althobaiti. Cross-Talk between Obesity and Diabetes: Introducing Polyphenols as an Effective Phytomedicine to Combat the Dual Sword Diabesity. Current Pharmaceutical Design 2022, 28 (19) , 1523-1542. https://doi.org/10.2174/1381612828666220628123224
42. Rasha M. Hassan, Islam H. Ali, Mohammed S. Abdel‐Maksoud, Heba M. I. Abdallah, Ahmed M. El Kerdawy, Francesca Sciandra, Iman A. Y. Ghannam. Design and synthesis of novel quinazolinone‐based fibrates as PPARα agonists with antihyperlipidemic activity. Archiv der Pharmazie 2022, 355 (3) https://doi.org/10.1002/ardp.202100399
43. Lucas Caruso, Nathalia Fonseca Nadur, Marina Brandão da Fonseca, Larissa de Almeida Peixoto Ferreira, Renata Barbosa Lacerda, Cedric Stephan Graebin, Arthur Eugen Kümmerle. The Design of Multi-target Drugs to Treat Cardiovascular Diseases: Two (or more) Birds on One Stone. Current Topics in Medicinal Chemistry 2022, 22 (5) , 366-394. https://doi.org/10.2174/1568026622666220201151248
44. Rosalba Leuci, Leonardo Brunetti, Antonio Laghezza, Luca Piemontese, Antonio Carrieri, Leonardo Pisani, Paolo Tortorella, Marco Catto, Fulvio Loiodice. A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE). Molecules 2022, 27 (3) , 958. https://doi.org/10.3390/molecules27030958
45. S. Yuvaraj, B.R. Prashantha Kumar. Peroxisome Proliferator-activated Receptor-γ As A Novel and Promising Target For Treating Cancer Via Regulation of Inflammation: A Brief Review. Mini-Reviews in Medicinal Chemistry 2022, 22 (1) , 3-14. https://doi.org/10.2174/1389557521666210422112740
46. Wei Wang, Yibao Ma, Tianhai He, Erin Mooney, Chunqing Guo, Xiang-Yang Wang, Xianjun Fang. Measurement of Fatty Acid Oxidation in Mammalian Cells. 2022, 49-62. https://doi.org/10.1007/978-1-0716-2128-8_5
47. Yihui Ruan, Xin Fang, Tingyue Guo, Yiting Liu, Yu Hu, Xuening Wang, Yuxin Hu, Lanyue Gao, Yongfang Li, Jingbo Pi, Yuanyuan Xu. Metabolic reprogramming in the arsenic carcinogenesis. Ecotoxicology and Environmental Safety 2022, 229 , 113098. https://doi.org/10.1016/j.ecoenv.2021.113098
48. Marialuigia Fantacuzzi, Rosa Amoroso, Alessandra Ammazzalorso. PPAR Ligands Induce Antiviral Effects Targeting Perturbed Lipid Metabolism during SARS-CoV-2, HCV, and HCMV Infection. Biology 2022, 11 (1) , 114. https://doi.org/10.3390/biology11010114
49. Ganesh Prasad Mishra, Rajesh Sharma, Mukul Jain, Debdutta Bandyopadhyay. Syntheses, biological evaluation of some novel substituted benzoic acid derivatives bearing hydrazone as linker. Research on Chemical Intermediates 2021, 47 (12) , 5061-5078. https://doi.org/10.1007/s11164-021-04555-y
50. Yuvaraj Sivamani, Dhivya Shanmugarajan, T. Durai Ananda Kumar, Syed Faizan, Bhavya Channappa, Namburu Lalitha Naishima, B.R. Prashantha Kumar. A promising in silico protocol to develop novel PPARγ antagonists as potential anticancer agents: Design, synthesis and experimental validation via PPARγ protein activity and competitive binding assay. Computational Biology and Chemistry 2021, 95 , 107600. https://doi.org/10.1016/j.compbiolchem.2021.107600
51. Jian-Ta Wang, Jin-Gang Peng, Jing Xia, Ji-Quan Zhang, Chu-Jiao Hu, Gao-Feng Zhu, Bing Guo, Lei Tang. Synthesis and biological evaluation of cajanonic acid A derivatives as potential PPARγ antagonists. Bioorganic & Medicinal Chemistry Letters 2021, 52 , 128410. https://doi.org/10.1016/j.bmcl.2021.128410
52. Rasha M. Hassan, Mona E. Aboutabl, Manuela Bozzi, Mohammed F. El-Behairy, Ahmed M. El Kerdawy, Beatrice Sampaolese, Claudia Desiderio, Federica Vincenzoni, Francesca Sciandra, Iman A.Y. Ghannam. Discovery of 4-benzyloxy and 4-(2-phenylethoxy) chalcone fibrate hybrids as novel PPARα agonists with anti-hyperlipidemic and antioxidant activities: Design, synthesis and in vitro/in vivo biological evaluation. Bioorganic Chemistry 2021, 115 , 105170. https://doi.org/10.1016/j.bioorg.2021.105170
53. Silvia Speca, Caroline Dubuquoy, Christel Rousseaux, Philippe Chavatte, Pierre Desreumaux, Paolo Spagnolo, . GED-0507 attenuates lung fibrosis by counteracting myofibroblast transdifferentiation in vivo and in vitro. PLOS ONE 2021, 16 (9) , e0257281. https://doi.org/10.1371/journal.pone.0257281
54. Rana A. Alaaeddine, Perihan A. Elzahhar, Ibrahim AlZaim, Wassim Abou-Kheir, Ahmed S.F. Belal, Ahmed F. El-Yazbi. The Emerging Role of COX-2, 15-LOX and PPARγ in Metabolic Diseases and Cancer: An Introduction to Novel Multi-target Directed Ligands (MTDLs). Current Medicinal Chemistry 2021, 28 (11) , 2260-2300. https://doi.org/10.2174/0929867327999200820173853
55. Jacopo Di Gregorio, Iole Robuffo, Sonia Spalletta, Giulia Giambuzzi, Vincenzo De Iuliis, Elena Toniato, Stefano Martinotti, Pio Conti, Vincenzo Flati. The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders. Frontiers in Cell and Developmental Biology 2020, 8 https://doi.org/10.3389/fcell.2020.607483
56. Silvia Speca, Caroline Dubuquoy, Christel Rousseaux, Philippe Chavatte, Pierre Desreumaux, Paolo Spagnolo. GED-0507 is a novel potential antifibrotic treatment option for pulmonary fibrosis. Cellular & Molecular Immunology 2020, 17 (12) , 1272-1274. https://doi.org/10.1038/s41423-020-0394-y
57. Yibao Ma, Wei Wang, Teja Devarakonda, Huiping Zhou, Xiang-Yang Wang, Fadi N. Salloum, Sarah Spiegel, Xianjun Fang. Functional analysis of molecular and pharmacological modulators of mitochondrial fatty acid oxidation. Scientific Reports 2020, 10 (1) https://doi.org/10.1038/s41598-020-58334-7
58. Xiaozheng Dou, Adam S. Duerfeldt. Small-Molecule Modulation of PPARs for the Treatment of Prevalent Vascular Retinal Diseases. International Journal of Molecular Sciences 2020, 21 (23) , 9251. https://doi.org/10.3390/ijms21239251
59. Leonardo Brunetti, Antonio Carrieri, Luca Piemontese, Paolo Tortorella, Fulvio Loiodice, Antonio Laghezza. Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors. International Journal of Molecular Sciences 2020, 21 (19) , 7026. https://doi.org/10.3390/ijms21197026
60. Runzhi Huang, Jiaqi Zhang, Mingxiao Li, Penghui Yan, Huabin Yin, Suna Zhai, Xiaolong Zhu, Peng Hu, Jiaxin Zhang, Ling Huang, Man Li, Zehui Sun, Tong Meng, Daoke Yang, Zongqiang Huang. The Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Pan-Cancer. PPAR Research 2020, 2020 , 1-19. https://doi.org/10.1155/2020/6527564
61. Michelyne Haroun. In Silico Design, Synthesis and Evaluation of Novel Series of Benzothiazole- Based Pyrazolidinediones as Potent Hypoglycemic Agents. Medicinal Chemistry 2020, 16 (6) , 812-825. https://doi.org/10.2174/1573406416666191227113716
62. M. Ottaviani, E. Flori, A. Mastrofrancesco, S. Briganti, V. Lora, B. Capitanio, C.C. Zouboulis, M. Picardo. Sebocyte differentiation as a new target for acne therapy: an in vivo experience. Journal of the European Academy of Dermatology and Venereology 2020, 34 (8) , 1803-1814. https://doi.org/10.1111/jdv.16252
63. L. Kemény, K. Szabó. Commentary on ‘Sebocyte differentiation as a new target for acne therapy: an in vivo experience’. Journal of the European Academy of Dermatology and Venereology 2020, 34 (8) , 1637-1638. https://doi.org/10.1111/jdv.16788
64. . Drug Targets. 2020, 1-96. https://doi.org/10.1002/9781119607311.ch1
65. Mounir A. A. Mohamed, Omyma A. Abd Allah, Adnan A. Bekhit, Asmaa M. Kadry, Ahmed M. M. El‐Saghier. Synthesis and antidiabetic activity of novel triazole derivatives containing amino acids. Journal of Heterocyclic Chemistry 2020, 57 (6) , 2365-2378. https://doi.org/10.1002/jhet.3951
66. Ghina Al Haj, Federica Rey, Toniella Giallongo, Mattia Colli, Barbara Marzani, Giammaria Giuliani, Alfredo Gorio, Gian Vicenzo Zuccotti, Anna Maria Di Giulio, Stephana Carelli. A New Selective PPARγ Modulator Inhibits Triglycerides Accumulation during Murine Adipocytes’ and Human Adipose-Derived Mesenchymal Stem Cells Differentiation. International Journal of Molecular Sciences 2020, 21 (12) , 4415. https://doi.org/10.3390/ijms21124415
67. Sharda Pasricha, Pragya Gahlot. Synthetic Strategies and Biological Potential of Coumarin-Chalcone Hybrids: A New Dimension to Drug Design. Current Organic Chemistry 2020, 24 (4) , 402-438. https://doi.org/10.2174/1385272824666200219091830
68. J. Chéret, I. Piccini, J. Hardman‐Smart, S. Ghatak, M. Alam, J. Lehmann, F. Jimenez, H. Erdmann, E. Poblet, N. Botchkareva, R. Paus, M. Bertolini. Preclinical evidence that the PPAR γ modulator, N ‐Acetyl‐ GED ‐0507‐34‐Levo, may protect human hair follicle epithelial stem cells against lichen planopilaris‐associated damage. Journal of the European Academy of Dermatology and Venereology 2020, 34 (4) https://doi.org/10.1111/jdv.16114
69. Haowen Jiang, X. Edward Zhou, Jingjing Shi, Zhi Zhou, Guanguan Zhao, Xinwen Zhang, Yili Sun, Kelly Suino-Powell, Lei Ma, Hui Gao, Xiyong Yu, Jia Li, Jingya Li, Karsten Melcher, H. Eric Xu, Wei Yi. Identification and structural insight of an effective PPARγ modulator with improved therapeutic index for anti-diabetic drug discovery. Chemical Science 2020, 11 (8) , 2260-2268. https://doi.org/10.1039/C9SC05487A
70. Aurélie Hurtevent, Morgan Le Naour, Veronique Leclerc, Pascal Carato, Patricia Melnyk, Nathalie Hennuyer, Bart Staels, Monique Beucher-Gaudin, Daniel-Henri Caignard, Catherine Dacquet, Nicolas Lebegue. Effect of 6-Benzoyl-benzothiazol-2-one scaffold on the pharmacological profile of α-alkoxyphenylpropionic acid derived PPAR agonists. Journal of Enzyme Inhibition and Medicinal Chemistry 2020, 35 (1) , 524-538. https://doi.org/10.1080/14756366.2020.1713771
71. Yunyuan Huang, Lin Wei, Xinya Han, Haifeng Chen, Yanliang Ren, Yanhong Xu, Rongrong Song, Li Rao, Chen Su, Chao Peng, Lingling Feng, Jian Wan. Discovery of novel allosteric site and covalent inhibitors of FBPase with potent hypoglycemic effects. European Journal of Medicinal Chemistry 2019, 184 , 111749. https://doi.org/10.1016/j.ejmech.2019.111749
72. Antonio Laghezza, Luca Piemontese, Paolo Tortorella, Fulvio Loiodice. An update about the crucial role of stereochemistry on the effects of Peroxisome Proliferator-Activated Receptor ligands. European Journal of Medicinal Chemistry 2019, 176 , 326-342. https://doi.org/10.1016/j.ejmech.2019.05.012
73. Alessandra Ammazzalorso, Laura De Lellis, Rosalba Florio, Antonio Laghezza, Barbara De Filippis, Marialuigia Fantacuzzi, Letizia Giampietro, Cristina Maccallini, Paolo Tortorella, Serena Veschi, Fulvio Loiodice, Alessandro Cama, Rosa Amoroso. Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines. Bioorganic & Medicinal Chemistry Letters 2019, 29 (16) , 2302-2306. https://doi.org/10.1016/j.bmcl.2019.06.020
74. Luciana Scotti, Alex France Messias Monteiro, Jéssika de Oliveira Viana, Francisco Jaime Bezerra Mendonça Junior, Hamilton M. Ishiki, Ernestine Nkwengoua Tchouboun, Rodrigo Santos, Marcus Tullius Scotti. Multi-Target Drugs Against Metabolic Disorders. Endocrine, Metabolic & Immune Disorders - Drug Targets 2019, 19 (4) , 402-418. https://doi.org/10.2174/1871530319666181217123357
75. Hua Zheng, Jinxia Wu, Hong Huang, Chunmei Meng, Weidong Li, Tianli Wei, Zhiheng Su. Metabolomics analysis of the protective effect of rubusoside on palmitic acid-induced lipotoxicity in INS-1 cells using UPLC-Q/TOF MS. Molecular Omics 2019, 15 (3) , 222-232. https://doi.org/10.1039/C9MO00029A
76. Md Mushtaque, Fernando Avecilla, Zubair Bin Hafeez, Mohammad Moshahid A. Rizvi. Synthesis, Characterization, Molecular Docking, and Anticancer Evaluation of 4‐Thiazolidinone Analogues. Journal of Heterocyclic Chemistry 2019, 56 (6) , 1794-1805. https://doi.org/10.1002/jhet.3549
77. Piotr Eder, Maciej Adler, Agnieszka Dobrowolska, Julian Kamhieh-Milz, Janusz Witowski. The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease. Cells 2019, 8 (6) , 628. https://doi.org/10.3390/cells8060628
78. Perihan A. Elzahhar, Rana Alaaeddine, Tamer M. Ibrahim, Rasha Nassra, Azza Ismail, Benjamin S.K. Chua, Rebecca L. Frkic, John B. Bruning, Nadja Wallner, Tilo Knape, Andreas von Knethen, Hala Labib, Ahmed F. El-Yazbi, Ahmed S.F. Belal. Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones. European Journal of Medicinal Chemistry 2019, 167 , 562-582. https://doi.org/10.1016/j.ejmech.2019.02.034
79. Jason D. Jacintho, Christopher S. Baccei, Yalda Bravo, Alex Broadhead, Austin Chen, Lucia Correa, Kim Fischer, Bryan Laffitte, Catherine Lee, Daniel S. Lorrain, Davorka Messmer, Peppi Prasit, Karin J. Stebbins, Nicholas S. Stock. Discovery of potent and selective PPARα/δ dual antagonists and initial biological studies. Bioorganic & Medicinal Chemistry Letters 2019, 29 (3) , 503-508. https://doi.org/10.1016/j.bmcl.2018.12.045
80. Steven P. Tanis, Jerry R. Colca, Timothy T. Parker, Gerald D. Artman, Scott D. Larsen, William G. McDonald, Robert C. Gadwood, Rolf F. Kletzien, James B. Zeller, Pil H. Lee, Wade J. Adams. PPARγ-sparing thiazolidinediones as insulin sensitizers. Design, synthesis and selection of compounds for clinical development. Bioorganic & Medicinal Chemistry 2018, 26 (22) , 5870-5884. https://doi.org/10.1016/j.bmc.2018.10.033
81. Manoj Govindarajulu, Priyanka D. Pinky, Jenna Bloemer, Nila Ghanei, Vishnu Suppiramaniam, Rajesh Amin. Signaling Mechanisms of Selective PPAR γ Modulators in Alzheimer’s Disease. PPAR Research 2018, 2018 , 1-20. https://doi.org/10.1155/2018/2010675
82. Tsuyoshi Shinozuka, Tomoharu Tsukada, Kunihiko Fujii, Eri Tokumaru, Kousei Shimada, Yoshiyuki Onishi, Yumi Matsui, Satoko Wakimoto, Masanori Kuroha, Tsuneaki Ogata, Kazushi Araki, Jun Ohsumi, Ryoko Sawamura, Nobuaki Watanabe, Hideki Yamamoto, Kazunori Fujimoto, Yoshiro Tani, Makoto Mori, Jun Tanaka. Discovery of DS-6930, a potent selective PPARγ modulator. Part II: Lead optimization. Bioorganic & Medicinal Chemistry 2018, 26 (18) , 5099-5117. https://doi.org/10.1016/j.bmc.2018.09.005
83. Tsuyoshi Shinozuka, Tomoharu Tsukada, Kunihiko Fujii, Eri Tokumaru, Kousei Shimada, Yoshiyuki Onishi, Yumi Matsui, Satoko Wakimoto, Masanori Kuroha, Tsuneaki Ogata, Kazushi Araki, Jun Ohsumi, Ryoko Sawamura, Nobuaki Watanabe, Hideki Yamamoto, Kazunori Fujimoto, Yoshiro Tani, Makoto Mori, Jun Tanaka. Discovery of DS-6930, a potent selective PPARγ modulator. Part I: Lead identification. Bioorganic & Medicinal Chemistry 2018, 26 (18) , 5079-5098. https://doi.org/10.1016/j.bmc.2018.09.006
84. Yibao Ma, Sarah M. Temkin, Adam M. Hawkridge, Chunqing Guo, Wei Wang, Xiang-Yang Wang, Xianjun Fang. Fatty acid oxidation: An emerging facet of metabolic transformation in cancer. Cancer Letters 2018, 435 , 92-100. https://doi.org/10.1016/j.canlet.2018.08.006
85. Xiao-Zheng Dou, Dinesh Nath, Younghwa Shin, Jian-Xing Ma, Adam S. Duerfeldt. Structure-guided evolution of a 2-phenyl-4-carboxyquinoline chemotype into PPARα selective agonists: New leads for oculovascular conditions. Bioorganic & Medicinal Chemistry Letters 2018, 28 (16) , 2717-2722. https://doi.org/10.1016/j.bmcl.2018.03.010
86. Jinyu Liu, Xiaoyan Su, Huachong Li, Li Fan, Yuanyuan Li, Xuemei Tang, Jufang Yan, Xin Chen, Feifei Chen, Jie Liu, Dacheng Yang. Design, synthesis, and evaluation of novel l-phenylglycine derivatives as potential PPARγ lead compounds. Bioorganic & Medicinal Chemistry 2018, 26 (14) , 4153-4167. https://doi.org/10.1016/j.bmc.2018.07.005
87. Fan Hong, Pengfei Xu, Yonggong Zhai. The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development. International Journal of Molecular Sciences 2018, 19 (8) , 2189. https://doi.org/10.3390/ijms19082189
88. Mohd. Javed Naim, Ozair Alam, Md. Jahangir Alam, Mohammad Shaquiquzzaman, Md. Mumtaz Alam, Vegi Ganga Modi Naidu. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole‐based 2,4‐thiazolidinedione derivatives as PPAR‐γ modulators. Archiv der Pharmazie 2018, 351 (3-4) https://doi.org/10.1002/ardp.201700223
89. Antonio Lavecchia, Carmen Cerchia. Selective PPARγ Modulators for Type 2 Diabetes Treatment: How Far have We Come and What does the Future Hold?. Future Medicinal Chemistry 2018, 10 (7) , 703-705. https://doi.org/10.4155/fmc-2018-0021
90. Christelle Colin, Maxime Meyer, Claudia Cerella, Alexandra Kleinclauss, G�rald Monard, Michel Boisbrun, Marc Diederich, St�phane Flament, Isabelle Grillier-Vuissoz, Sandra Kuntz. Biotinylation enhances the anticancer effects of 15d‑PGJ2 against breast cancer cells. International Journal of Oncology 2018, https://doi.org/10.3892/ijo.2018.4338
91. Cristina M. Alcántara, Andrés R. Alcántara. Biocatalyzed synthesis of antidiabetic drugs: A review. Biocatalysis and Biotransformation 2018, 36 (1) , 12-46. https://doi.org/10.1080/10242422.2017.1323887
92. Bharat Lagu, Arthur F. Kluge, Ross A. Fredenburg, Effie Tozzo, Ramesh S. Senaiar, Mahaboobi Jaleel, Sunil K. Panigrahi, Nirbhay K. Tiwari, Narasimha R. Krishnamurthy, Taisuke Takahashi, Michael A. Patane. Novel highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulators with pharmacokinetic properties suitable for once-daily oral dosing. Bioorganic & Medicinal Chemistry Letters 2017, 27 (23) , 5230-5234. https://doi.org/10.1016/j.bmcl.2017.10.037
93. Sabina Yasmin, Fabio Capone, Antonio Laghezza, Fabrizio Dal Piaz, Fulvio Loiodice, Viswanathan Vijayan, Velmurugan Devadasan, Susanta K. Mondal, Özlem Atlı, Merve Baysal, Ashok K. Pattnaik, Venkatesan Jayaprakash, Antonio Lavecchia. Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes. Scientific Reports 2017, 7 (1) https://doi.org/10.1038/s41598-017-14776-0
94. Mathurin Fumery, Silvia Speca, Audrey Langlois, Anne‐Marie Davila, Caroline Dubuquoy, Marta Grauso, Anthony Martin Mena, Martin Figeac, Daniel Metzger, Christel Rousseaux, Jean‐Frederic Colombel, Laurent Dubuquoy, Pierre Desreumaux, Benjamin Bertin. Peroxisome proliferator‐activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut. EMBO Molecular Medicine 2017, 9 (11) , 1471-1481. https://doi.org/10.15252/emmm.201707795
95. Alessandra Ammazzalorso, Laura De Lellis, Rosalba Florio, Isabella Bruno, Barbara De Filippis, Marialuigia Fantacuzzi, Letizia Giampietro, Cristina Maccallini, Silvia Perconti, Fabio Verginelli, Alessandro Cama, Rosa Amoroso. Cytotoxic effect of a family of peroxisome proliferator‐activated receptor antagonists in colorectal and pancreatic cancer cell lines. Chemical Biology & Drug Design 2017, 90 (5) , 1029-1035. https://doi.org/10.1111/cbdd.13026
96. Handong Niu, Wenbao Wang, Jinyan Li, Yu Lei, Yong Zhao, Weixu Yang, Chaoyue Zhao, Bin Lin, Shaojiang Song, Shaojie Wang. A novel structural class of coumarin-chalcone fibrates as PPARα/γ agonists with potent antioxidant activities: Design, synthesis, biological evaluation and molecular docking studies. European Journal of Medicinal Chemistry 2017, 138 , 212-220. https://doi.org/10.1016/j.ejmech.2017.06.033
97. Cristina Maccallini, Adriano Mollica, Rosa Amoroso. The Positive Regulation of eNOS Signaling by PPAR Agonists in Cardiovascular Diseases. American Journal of Cardiovascular Drugs 2017, 17 (4) , 273-281. https://doi.org/10.1007/s40256-017-0220-9
98. A. Mastrofrancesco, M. Ottaviani, G. Cardinali, E. Flori, S. Briganti, M. Ludovici, C.C. Zouboulis, V. Lora, E. Camera, M. Picardo. Pharmacological PPARγ modulation regulates sebogenesis and inflammation in SZ95 human sebocytes. Biochemical Pharmacology 2017, 138 , 96-106. https://doi.org/10.1016/j.bcp.2017.04.030
99. Ashok Kumar Singh, Avinash C. Tripathi, Aseem Tewari, Viney Chawla, Shailendra K. Saraf. Design and microwave facilitated green synthesis of 2-[4-(3-carboxymethyl, methoxy carbonylmethyl-2,4-dioxo and 4-oxo-2-thioxo-thiazolidin-5-ylidenemethyl)-phenoxy]-2 and 3-methyl propionic acid ethyl ester derivatives: a novel structural class of antidyslipidemic agents. Medicinal Chemistry Research 2017, 26 (7) , 1535-1549. https://doi.org/10.1007/s00044-017-1875-0
100. Daniela Rigano, Carmina Sirignano, Orazio Taglialatela-Scafati. The potential of natural products for targeting PPAR α. Acta Pharmaceutica Sinica B 2017, 7 (4) , 427-438. https://doi.org/10.1016/j.apsb.2017.05.005